PROTOCOL NIDA-CTN-0052


A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence

Theresa Winhusen, PhD
Lead Investigator

University of Cincinnati/CinARC
winhusen@carc.uc.edu

The primary objective of this study is to evaluate the efficacy of of buspirone, relative to placebo, in preventing relapse in cocaine-dependent adults in inpatient/residential treatment who are planning to enter outpatient treatment upon inpatient/residential discharge. Secondary objectives include evaluating the impact of buspirone, relative to placebo, on other drug-abuse outcomes and on factors that may mediate buspirone's efficacy as a relapse-prevention treatment.

CTN-0052 Study Protocol

RELATED RESOURCES

snowflake

Publications about CTN-0052


NODES & CTPs SEARCH LINK
Ohio Valley (lead) search www
  Maryhaven, Inc. search www
Appalachian Tri-State search www
  Addiction Medicine Services search www
Delaware Valley search www
  Penn Presbyterian Medical Center search www
Florida Node Alliance search www
  Gateway Community Services search www
Southern Consortium search www
  Lexington/Richland Alcohol and Drug Abuse Council search www
  Morris Village search www
Texas search www
Nexus Recovery Center search www
OTHER RESOURCES
NIDA protocol page www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2013 -- http://ctndisseminationlibrary.org/protocols/ctn0052.htm
info@ctndisseminationlibrary.org